MARKET

IRMD

IRMD

IRadimed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.76
0.00
0.00%
Opening 10:16 09/23 EDT
OPEN
33.76
PREV CLOSE
33.76
HIGH
33.76
LOW
33.76
VOLUME
15
TURNOVER
--
52 WEEK HIGH
40.51
52 WEEK LOW
20.52
MARKET CAP
415.86M
P/E (TTM)
112.20
1D
5D
1M
3M
1Y
5Y
IRadimed's (NASDAQ:IRMD) Returns On Capital Not Reflecting Well On The Business
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Simply Wall St. · 09/16 12:54
Insider Sell: Iradimed
MT Newswires · 09/09 16:30
4 Small-Cap Medical Device Stocks Rated 'Strong Buy'
StockNews.com · 08/25 13:51
Insider Trends: Iradimed Insider Extends 90-Day Selling Trend
MT Newswires · 08/11 17:45
Roth Capital Maintains Buy on iRadimed, Raises Price Target to $36
Roth Capital analyst Scott Henry maintains iRadimed (NASDAQ:IRMD) with a Buy and raises the price target from $32 to $36.
Benzinga · 08/02 13:01
--Roth Capital Adjusts iRadimed's Price Target to $36 from $32, Keeps Buy Rating
MT Newswires · 08/02 11:26
IRadimed Corporation's (NASDAQ:IRMD) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
IRadimed's (NASDAQ:IRMD) stock is up by a considerable 19% over the past three months. However, we decided to pay...
Simply Wall St. · 08/02 08:24
BRIEF-IRadimed Reports Q2 GAAP Earnings Per Share $0.12
reuters.com · 07/30 11:51
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IRMD. Analyze the recent business situations of IRadimed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IRMD stock price target is 38.00 with a high estimate of 40.00 and a low estimate of 36.00.
EPS
Institutional Holdings
Institutions: 99
Institutional Holdings: 5.82M
% Owned: 47.27%
Shares Outstanding: 12.32M
TypeInstitutionsShares
Increased
17
267.20K
New
11
46.24K
Decreased
24
245.03K
Sold Out
4
12.69K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.68%
Healthcare Equipment & Supplies
+0.71%
Key Executives
Chairman/President/Chief Executive Officer/Founder/Director
Roger Susi
Chief Financial Officer/Chief Operating Officer/Secretary
Chris Scott
Independent Director
Monty Allen
Independent Director
James Hawkins
Independent Director
Anthony Vuoto
No Data
About IRMD
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.

Webull offers kinds of Iradimed Corp stock information, including NASDAQ:IRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRMD stock methods without spending real money on the virtual paper trading platform.